How do you manage classical early stage Hodgkin lymphoma patients when an ESR is not checked as part of their workup?

Topics: Hematologic Malignancies • Radiation Oncology • Hematology

For example, would you go ahead with 20 Gy of ISRT if medical oncology has already treated a stage I-IIA patient with 2 cycles of ABVD meeting all other favorable criteria by the GHSG criteria except the ESR was not checked prior to treatment? Or would you recommend a different approach?

Answer from: Radiation Oncologist at Academic Institution

I personally don't think ESR plays a huge factor in the management of early stage Hodgkin Lymphoma now in the era of PET-adapted treatment selection. So, if a patient has very favorable stage I-IIA HL meeting all other criteria by the GHSH study and is interested to not have combined modality treatm...

Comments

Radiation Oncologist at Duke University Medical Center
I'm not sure I understand Dr Huang's answer comple...

Related Questions